相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
David A. Sykes et al.
MOLECULAR PHARMACOLOGY (2016)
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment
Ian P. Hall et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics
Z. Diamant et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis
Norbert Krug et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
D. Price et al.
RESPIRATORY MEDICINE (2013)
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
N. Barnes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger
Soren Erik Pedersen et al.
PEDIATRIC PULMONOLOGY (2011)
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues
Paolo Montuschi
FRONTIERS IN PHARMACOLOGY (2011)
Molecular adapters in FcεRI signaling and the allergic response
J Rivera
CURRENT OPINION IN IMMUNOLOGY (2002)
分享论文
